Evidence map›Paper›PMID 32882184›Full record

ReviewActas dermo-sifiliograficas2020

Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19).

J M Carrascosa, V Morillas, I Bielsa, M Munera-Campos

Abstract readReview
In one paragraph

Review in Actas dermo-sifiliograficas, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Present and future: Infectious tropical travel rashes and the impact of climate change.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2023
    Review
  5. Course and outcome of chilblain-like acral lesions during COVID-19 pandemic.Journal of the European Academy of Dermatology and Venereology : JEADV · 2023
    Article
  6. Review
  7. Review
  8. Cutaneous Manifestations of COVID-19 in the Lower Limbs: A Narrative Review.International journal of environmental research and public health · 2022
    Review
  9. Cutaneous Manifestations of SARS-CoV-2 Infection.American journal of clinical dermatology · 2022
    Review
  10. Acro-ischemic lesions in COVID-19 patients: A case series.Journal of cosmetic dermatology · 2022
    Article
  11. COVID toes following vaccination.Proceedings (Baylor University. Medical Center) · 2022
    Review
  12. FMC : Formacion medica continuada en atencion primaria · 2021
    Article
  13. Review
  14. Article
  15. Article
  16. Observational
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

J M CarrascosaServicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, España. Electronic address: jmcarrascosac@hotmail.com.
V MorillasServicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, España.
I BielsaServicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, España.
M Munera-CamposServicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus2 (SARS-CoV-2), has had enormous health, economic, and social consequences. The clinical spectrum of cutaneous manifestations observed in patients with COVID-19 is both heterogeneous and complex. To date, reports have identified 5main categories: acral lesions, vesicular rashes, urticarial rashes, maculopapular rashes, and livedoid and necrotic lesions. However, these will probably be modified as new information comes to light. Cutaneous manifestations associated with COVID-19 probably reflect the activation of pathogenic pathways by the virus or a response to inflammatory processes, vascular or systemic complications, or even treatments. Familiarity with the cutaneous manifestations of COVID-19 may enable early diagnosis or help guide prognosis.

Indexed as

SARS-CoV-2COVID-19ExanthemaFoot DermatosesHumansNecrosisSkinSkin Diseases, ViralToesUrticariaAcralAcral lesionsBlisterCOVID-19ExantemaExanthemaLivedoLivedoid lesionsPielSARS-CoV-2SARS-CoV-2 infectionSkinUrticariaVesículasViral diseasesVirosis

Identifiers

PMID32882184
PMCPMC7458046

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.